Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Tumour Metabolism in Cisplatin Resistance
Lude Wang, Xiaoya Zhao, Jianfei Fu, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Cisplatin for cancer therapy and overcoming chemoresistance
Ranmali Ranasinghe, Michael L. Mathai, Anthony Zulli
Heliyon (2022) Vol. 8, Iss. 9, pp. e10608-e10608
Open Access | Times Cited: 77
Coumarin–benzimidazole hybrids: A review of developments in medicinal chemistry
Arya C. G, Ramesh Gondru, Yupeng Li, et al.
European Journal of Medicinal Chemistry (2021) Vol. 227, pp. 113921-113921
Closed Access | Times Cited: 92
Impact of cancer metabolism on therapy resistance – Clinical implications
Ana Cristina Gonçalves, Elena Richiardone, Joana Jorge, et al.
Drug Resistance Updates (2021) Vol. 59, pp. 100797-100797
Open Access | Times Cited: 90
Ribonucleotide reductase M2 (RRM2): Regulation, function and targeting strategy in human cancer
Zanwen Zuo, Zerong Zhou, Yuzhou Chang, et al.
Genes & Diseases (2022) Vol. 11, Iss. 1, pp. 218-233
Open Access | Times Cited: 50
Exploring the Use of Cold Atmospheric Plasma to Overcome Drug Resistance in Cancer
Dzohara Murillo, Carmen Huergo, Borja Gallego, et al.
Biomedicines (2023) Vol. 11, Iss. 1, pp. 208-208
Open Access | Times Cited: 40
Moving beyond cisplatin resistance: mechanisms, challenges, and prospects for overcoming recurrence in clinical cancer therapy
Rui Fu, Borui Zhao, Min Chen, et al.
Medical Oncology (2023) Vol. 41, Iss. 1
Closed Access | Times Cited: 24
Advancements in platinum-based anticancer drug development: A comprehensive review of strategies, discoveries, and future perspectives
Debsankar Sahoo, Priya Deb, Tamal Basu, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 112, pp. 117894-117894
Closed Access | Times Cited: 15
Epigenetic modification of ferroptosis by non-coding RNAs in cancer drug resistance
Hongquan Wang, Joshua S. Fleishman, Sihang Cheng, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Advances in Understanding Cisplatin-Induced Toxicity: Molecular Mechanisms and Protective Strategies
Elsayed A. Elmorsy, Sameh Saber, Rabab S. Hamad, et al.
European Journal of Pharmaceutical Sciences (2024), pp. 106939-106939
Open Access | Times Cited: 14
Comprehensive Insights into Oral Squamous Cell Carcinoma: Diagnosis, Pathogenesis, and Therapeutic Advances
Dharshini Jagadeesan, Kathiresan V. Sathasivam, Neeraj Kumar Fuloria, et al.
Pathology - Research and Practice (2024) Vol. 261, pp. 155489-155489
Closed Access | Times Cited: 13
Pt(IV) Prodrugs with Non-Steroidal Anti-inflammatory Drugs in the Axial Position
Daniil Spector, Kirill G. Pavlov, Roman Akasov, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 12, pp. 8227-8244
Closed Access | Times Cited: 36
Cisplatin Resistance in Cancer Therapy: Causes and Overcoming Strategies
S Shruthi, K. Bhasker Shenoy
ChemistrySelect (2024) Vol. 9, Iss. 25
Closed Access | Times Cited: 7
Interfering with lipid metabolism through targeting CES1 sensitizes hepatocellular carcinoma for chemotherapy
Gang� Li, Xin Li, Iqbal Mahmud, et al.
JCI Insight (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 24
The role of Extracellular Vesicles in glycolytic and lipid metabolic reprogramming of cancer cells: Consequences for drug resistance
Bárbara Polónia, Cristina P. R. Xavier, Joanna Kopecka, et al.
Cytokine & Growth Factor Reviews (2023) Vol. 73, pp. 150-162
Open Access | Times Cited: 15
Deregulated Metabolic Pathways in Ovarian Cancer: Cause and Consequence
Roopak Murali, Vaishnavi Balasubramaniam, Satish Srinivas, et al.
Metabolites (2023) Vol. 13, Iss. 4, pp. 560-560
Open Access | Times Cited: 14
Platinum iodido drugs show potential anti-tumor activity, affecting cancer cell metabolism and inducing ROS and senescence in gastrointestinal cancer cells
Jorge M. Herrero, Sonia Alcalá, Laura Ruiz, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 6
Assessing the ability of polysaccharides extracted from date palm fruit to salvage Wistar rats from cisplatin-linked hepatic damage
Omowumi Oyeronke Adewale, Roseline Faderera Oyelola, Johnson Olaleye Oladele, et al.
Pharmacological Research - Modern Chinese Medicine (2024) Vol. 11, pp. 100400-100400
Open Access | Times Cited: 4
Pioglitazone enhances cisplatin’s impact on triple-negative breast cancer: Role of PPARγ in cell apoptosis
Qamraa H. Alqahtani, Layla A. Al‐Kharashi, Hanaa N. Alajami, et al.
Saudi Pharmaceutical Journal (2024) Vol. 32, Iss. 5, pp. 102059-102059
Open Access | Times Cited: 4
Cisplatin Resistance and Metabolism: Simplification of Complexity
Nikolay V. Pervushin, Maria A. Yapryntseva, Mikhail A. Panteleev, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 3082-3082
Open Access | Times Cited: 4
Isoalantolactone Suppresses Glycolysis and Resensitizes Cisplatin-Based Chemotherapy in Cisplatin-Resistant Ovarian Cancer Cells
Jaemoo Chun
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12397-12397
Open Access | Times Cited: 11
Apoptosis induction and tumor growth suppression by hydroxyapatite nanoparticles–cisplatin combined treatment in Ehrlich solid carcinoma-bearing mice
Shaymaa M. Eissa, Asmaa M. Mahfouz, Saad M. El‐Gendy, et al.
Beni-Suef University Journal of Basic and Applied Sciences (2025) Vol. 14, Iss. 1
Open Access
Two multifunctional zero-dimensional Gd(III) complexes: Magnetocaloric effect, inhibition of cell proliferation, migration and induction of apoptosis in lung cancer cells
Shouying Cao, Yaqing Xie, Xiaotong Lu, et al.
Journal of Inorganic Biochemistry (2025) Vol. 265, pp. 112832-112832
Closed Access
Unveiling the promising in vitro anticancer activity of lipophilic platinum(II) complexes containg (1S, 4R, 5R)-4-(4-phenyl-1H-1,2,3-triazol-1-yl)-2-((S)-1-phenylethyl)-2-azabicyclo[3.2.1]octane: spectroscopical characterization and DFT calulation
Adriana Kaszuba, Jerzy Sitkowski, Tadeusz Muzioł, et al.
Dalton Transactions (2025)
Closed Access
Organoid models of ovarian cancer: resolving immune mechanisms of metabolic reprogramming and drug resistance
Lanyue Zhang, Jiangnan Zhao, Changqing Su, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Synthesis and biological evaluation of salophen nickel(II) and cobalt(III) complexes as potential anticancer compounds
N. Benjamin, Daniel Baecker, Hubert Descher, et al.
Archiv der Pharmazie (2023) Vol. 356, Iss. 5
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top